Loading clinical trials...
Loading clinical trials...
A Single-center, Open, Phase I Clinical Trial to Evaluate Safety of S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months
Conditions
Interventions
S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine
S.Flexneriza-S.Sonnei Bivalent Conjugate Vaccine
Locations
1
China
Yizhou Center for Disease Control and Prevention
Yizhou, Guangxi, China
Start Date
July 18, 2017
Primary Completion Date
January 28, 2018
Completion Date
February 8, 2018
Last Updated
October 17, 2018
NCT02736968
NCT05156528
NCT03527173
NCT03491228
NCT02797236
NCT01618591
Lead Sponsor
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions